Results 171 to 180 of about 420,896 (315)
The model shows the probiotics screening and underlying mechanisms of F. rodentiumn in alleviating IR‐induced tissue injury. Stress‐induced STAT3 mitochondria localization decreases F. rodentium abundance and butyrate concentration. Supplementation of F.
Hanyong Zhu +17 more
wiley +1 more source
The Emergence of Subclones Following Initial Chemotherapy in Mixed Phenotype Acute Leukemia. [PDF]
Murao T +7 more
europepmc +1 more source
Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects [PDF]
R. Egbring +3 more
openalex +1 more source
This study elucidates how DCAF12 facilitates non‐degradative ubiquitination to stabilize TRiC/CCT, thereby enhancing the folding capacity of chaperonins. This mechanism promotes the maturation of cytoskeletal proteins and activates key oncogenic drivers, including YAP, STAT3, and mTOR, ultimately driving metastatic progression in lung cancer.
Zhenyi Wang +13 more
wiley +1 more source
In superficial second‐degree burn wounds, Gb3 turns on genes related to papillary cells through the FGF2 signaling pathway. This increases the ability of cells to break down fibrin and decreases fibrosis, which ultimately prevents scar formation in burn injuries.
Sujie Xie +13 more
wiley +1 more source
A shadow in the treatment of acute leukemia: lineage switch. [PDF]
Zhou Q, Wang Y.
europepmc +1 more source
Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase [PDF]
J Breton-Gorius +4 more
openalex +1 more source
COP9 signalosome subunit 6 (CSN6) promotes the auto‐ubiquitination and degradation of DDB1‐CUL4 associated factor 1 (DCAF1), thereby antagonizing DCAF1‐mediated ubiquitination of Nucleophosmin (NPM1). This stabilization of NPM1 enhances the ribosome biogenesis process and the translation of specific gemcitabine‐resistance proteins, ultimately driving ...
Yijing Zhang +14 more
wiley +1 more source
Leukoreduction in a dog with acute leukemia. [PDF]
Hanratty B +3 more
europepmc +1 more source
CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang +16 more
wiley +1 more source

